OMC Restrictions quantitatives

Singapour #9107 (v.1)

Données de base

Notifiée dans
Validité de la version
11/04/2023 - 01/09/2024
Ancienne version v.1
Membre présentant le rapport
Singapour
En vigueur depuis
Date de fin
En vigueur
Description générale
Non-automatic licence for the import of Chinese proprietary medicines (CPMs)
Base légale nationale
Medicines Act, 1975
Mécanisme administratif
While the controls of chemical and biologic drugs have been transferred from the Medicines Act to the Health Products Act from 1 Nov 2016, CPMs will continue to be regulated under the Medicines Act for now.

More information can be found at: https://www.hsa.gov.sg/.

Administered by HSA.
Entités responsables
Version du SH
HS 2022
Cote du document de l'OMC mentionné

Métadonnées

Justifications au regard de l'OMC

XX:(b) - (b) necessary to protect human, animal or plant life or health;

GATT 1994 (GATT 1947 provisions)

Signalé comme: Article XX(b) of the GATT
Engagements internationaux (hors OMC)
Partenaires concernés
Partenaires non concernés

Mesures

Restrictions signalées
NAL
Cote
NAL

Lignes tarifaires
12
Chapter 12
Chinese proprietary medicines (CPMs) refer to medicinal products, used according to the traditional...
13
Chapter 13
Chinese proprietary medicines (CPMs) refer to medicinal products, used according to the traditional...
30
Chapter 30
Chinese proprietary medicines (CPMs) refer to medicinal products, used according to the traditional...